Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „enzalutamide“
Suchtreffer
Begriffe & Kennungen
Enzalutamide Viatris · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEnzalutamide Viatris · 4.8 · Seizure In controlled clinical studies, 31 patients (0.6%) experienced a seizure out of 5 112 patients treated
Eintrag öffnenEnzalutamide Viatris · 4.8 · Seizure occurred in 0.6% of enzalutamide-treated patients, 0.1% of placebo-treated patients and 0.3% in bicalu
Eintrag öffnenEnzalutamide Viatris · 4.8 · Stevens-Johnson syndrome has been reported with enzalutamide treatment (see section 4.4).
Eintrag öffnenEnzalutamide Viatris · 4.8 · Summary of the safety profile
Eintrag öffnenEnzalutamide Viatris · 4.8 · Table 1: Adverse reactions identified in controlled clinical trials and post-marketing
Eintrag öffnenEnzalutamide Viatris · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenEnzalutamide Viatris · 4.8 · The mechanism by which enzalutamide may lower the seizure threshold is not known but could be related to data
Eintrag öffnenEnzalutamide Viatris · 4.8 · The most common adverse reactions are asthenia/fatigue, hot flush, hypertension, fractures, fall and headache.
Eintrag öffnenGhryvelin (previously Macimorelin Aeterna Zentaris) · 4.5 · Administration of a CYP3A4 inducer (such as carbamazepine, dabrafenib, efavirenz, enzalutamide, eslicarbazepin
Eintrag öffnenIbrance · 4.5 · The concomitant use of strong CYP3A inducers including, but not limited to: carbamazepine, enzalutamide, pheny
Eintrag öffnenIbrance · 4.5 · The concomitant use of strong CYP3A inducers including, but not limited to: carbamazepine, enzalutamide, pheny
Eintrag öffnenOrgovyx · 4.5 · Enzalutamide Therapeutic Expected: ↔ Expected: ↔ Enzalutamide may dose for decrease (CYP3A4 Orgovyx induction)
Eintrag öffnenOrgovyx · 4.5 · Therapeutic dose for Enzalutamide Expected: Expected: Orgovyx ↔ ↔ (CYP2C8 and CYP3A4 substrate)
Eintrag öffnenOrgovyx · 4.5 · Therefore, no dose modifications are recommended for co- administration of relugolix and enzalutamide.
Eintrag öffnenPaxlovid · 4.3 · • Antibiotics: rifampicin, rifapentine • Anticancer drugs: apalutamide, enzalutamide • Anticonvulsants: carbam
Eintrag öffnenRetsevmo · 4.5 · 9 amodiaquine, cerivastatin, enzalutamide, paclitaxel, repaglinide, torasemide, sorafenib, rosiglitazone, bupr
Eintrag öffnenTalzenna · 4.5 · Effect of enzalutamide Co-administration with 160 mg enzalutamide increases talazoparib exposure approximately
Eintrag öffnenTalzenna · 4.8 · In patients with mCRPC treated with talazoparib in combination with enzalutamide, anaemia led to talazoparib d
Eintrag öffnenXtandi · 4.5 · 35 Potential for enzalutamide to affect exposures to other medicinal products
Eintrag öffnen